8Discussion: However, in the patient on DTG/TDF this ""hypersensitizing"" effect may have been reduced by the presence of baseline
M41L and
T215Y which in combination are ass
Result: The other patient was switched from TDF/FTC/EVG/c to DTG/ABC/3TC (Table 2, Patient 6) and historical genotypic testing revealed an
M184V/I,
M41L,
T215Y and L74/I which predicted that DTG was the only fully active agent in the study DCR.
Discussion: Among the three patients on functional dual therapy with persistent viremia and documented non-adherence, two were on DTG/ABC and only had baseline
M184V/I whereas the other was on DTG/TDF and had baseline
M184V/I,
M41L and
T215Y.